HilleVax is a Massachusetts-based biopharmaceutical company that develops and commercializes novel vaccines for the treatment of acute gastroenteritis disorders.
Business Model:
Revenue: $0
Employees: 11-50
Address: 75 State Street
City: Boston
State: MA
Zip: 02109
Country: US
HilleVax is a Massachusetts-based biopharmaceutical company that develops and commercializes novel vaccines for the treatment of acute gastroenteritis disorders.
Contact Phone:
+18883404544
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
4/29/2022
IPO Valuation:
$538M
Ticker Symbol:
HLVX
IPO Price:
$17/share
Amount Raised:
$230M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2021 | Equity | 14 | $135M |
Abingworth BVF Partners Catalys Pacific Deerfield Franklin Templeton Frazier Healthcare Partners Greenspring Associates Lightspeed Venture Partners Perceptive Advisors Qiming Venture Partners USA RA Capital Management Richard King Mellon Foundation Sahsen Ventures Samsara BioCapital Abingworth BVF Partners Catalys Pacific Deerfield Franklin Templeton Frazier Healthcare Partners Greenspring Associates Lightspeed Venture Partners Perceptive Advisors Qiming Venture Partners USA RA Capital Management Richard King Mellon Foundation Sahsen Ventures Samsara BioCapital |
4/2022 | IPO | $200M |
|
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|